Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Armitage, P.
1971.
A note on the safety testing of vaccines.
Journal of Hygiene,
Vol. 69,
Issue. 1,
p.
95.
Anderson, E.C.
Masters, R.C.
and
Mowat, G.N.
1971.
Immune Response of Pigs to Inactivated Foot-and-Mouth Disease Vaccines.
Research in Veterinary Science,
Vol. 12,
Issue. 4,
p.
342.
Morrow, A. W.
1972.
Concentration of the virus of foot-and-mouth disease in a tangential flow ultrafiltration unit.
Journal of Applied Chemistry and Biotechnology,
Vol. 22,
Issue. 4,
p.
501.
Morrow, A. W.
1972.
Concentration of the virus of foot‐and‐mouth disease in a tangential flow ultrafiltration unit.
Journal of Applied Chemistry and Biotechnology,
Vol. 22,
Issue. 4,
p.
501.
Mowat, G. N.
Prince, M. J.
Spier, R. E.
and
Staple, R. F.
1974.
Preliminary studies on the development of a swine vesicular disease vaccine.
Archiv f�r die gesamte Virusforschung,
Vol. 44,
Issue. 4,
p.
350.
Staple, R. F.
Morrow, A. W.
and
Fletton, B. W.
1975.
The effect of acetylethyleneimine upon a strain of inactivated foot-and-mouth disease virus stored at 4� C.
Archives of Virology,
Vol. 47,
Issue. 4,
p.
331.
Pay, T.W.F.
1978.
A Review of Quality Control Methods.
British Veterinary Journal,
Vol. 134,
Issue. 1,
p.
76.
Rweyemamu, M. M.
Terry, G.
and
Pay, T. W. F.
1979.
Stability and immunogenicity of empty particles of foot-and-mouth disease virus.
Archives of Virology,
Vol. 59,
Issue. 1-2,
p.
69.
Leeuw, P. W. De
Tiessink, J. W. A.
and
Bekkum, J. G. Van
1980.
Aspects of heat inactivation of foot-and-mouth disease virus in milk from intramammarily infected susceptible cows.
Journal of Hygiene,
Vol. 84,
Issue. 2,
p.
159.
Preston, K.J.
Owens, Hilary
and
Mowat, G.N.
1982.
Sources of variations encountered during the selection and production of three strains of FMD virus for the development of vaccine for use in Nigeria.
Journal of Biological Standardization,
Vol. 10,
Issue. 1,
p.
35.
Barteling, S.J.
1983.
Innocuity testing of foot-and-mouth disease vaccines II. Aziridine-inactivated antigen produced in baby hamster kidney cells.
Journal of Biological Standardization,
Vol. 11,
Issue. 4,
p.
305.
Barteling, S.J.
Woortmeyer, R.
and
Visser, N.
1983.
Innocuity testing of foot-and-mouth disease vaccines I. Formaldeyde-inactivated alhydrogel vaccines.
Journal of Biological Standardization,
Vol. 11,
Issue. 4,
p.
297.
Hendriksen, Coenraad F. M.
1988.
Laboratory Animals in Vaccine Production and Control.
p.
125.
Ferris, N.P.
Kitching, R.P.
Oxtoby, J.M.
Philpot, R.M.
and
Rendle, R.
1990.
Use of inactivated foot-and-mouth disease virus antigen in liquid-phase blocking ELISA.
Journal of Virological Methods,
Vol. 29,
Issue. 1,
p.
33.
Barnett, P.
Garland, A.J.M.
Kitching, R.P.
and
Schermbrucker, C.G.
2002.
Aspects of emergency vaccination against foot-and-mouth disease.
Comparative Immunology, Microbiology and Infectious Diseases,
Vol. 25,
Issue. 5-6,
p.
345.
Doel, T.R
2003.
FMD vaccines.
Virus Research,
Vol. 91,
Issue. 1,
p.
81.
Barteling, S
2004.
Foot and Mouth Disease.
p.
306.
Leeuw, P. W.
Tiessink, J. W. A.
and
Frenkel, S.
2010.
Vaccination of Pigs with Formaldehyde Inactivated Aluminium Hydroxide Foot-and-Mouth Disease Vaccines, Potentiated with Diethylaminoethyldextran (DEAE-D).
Zentralblatt für Veterinärmedizin Reihe B,
Vol. 26,
Issue. 2,
p.
85.
Motamedi-Sedeh, Farahnaz
Soleimanjahi, Hoorieh
Jalilian, Amir Reza
Mahravani, Homayoon
Shafaee, Kamalodin
Sotoodeh, Masood
Taherkarami, Hamdolah
and
Jairani, Faramarz
2015.
Development of Protective Immunity against Inactivated Iranian Isolate of Foot-and-Mouth Disease Virus Type O/IRN/2007 Using Gamma Ray-Irradiated Vaccine on BALB/c Mice and Guinea Pigs.
Intervirology,
Vol. 58,
Issue. 3,
p.
190.
Barteling, S.J.
2019.
Foot and Mouth Disease.
p.
305.